# A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years

> **NCT07632274** · PHASE1 · RECRUITING · sponsor: **HALEON** · enrollment: 12 (estimated)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Test Product

## Key facts

- **NCT ID:** NCT07632274
- **Lead sponsor:** HALEON
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-19
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07632274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07632274, "A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07632274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*